GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbury Ltd (BOM:524212) » Definitions » Days Sales Outstanding

Wanbury (BOM:524212) Days Sales Outstanding : 60.56 (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Wanbury Days Sales Outstanding?

Wanbury's average Accounts Receivable for the three months ended in Mar. 2025 was ₹1,142 Mil. Wanbury's Revenue for the three months ended in Mar. 2025 was ₹1,720 Mil. Hence, Wanbury's Days Sales Outstanding for the three months ended in Mar. 2025 was 60.56.

The historical rank and industry rank for Wanbury's Days Sales Outstanding or its related term are showing as below:

BOM:524212' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.84   Med: 49.16   Max: 72.22
Current: 64.13

During the past 13 years, Wanbury's highest Days Sales Outstanding was 72.22. The lowest was 34.84. And the median was 49.16.

BOM:524212's Days Sales Outstanding is ranked better than
58.87% of 958 companies
in the Drug Manufacturers industry
Industry Median: 72.225 vs BOM:524212: 64.13

Wanbury's Days Sales Outstanding increased from Mar. 2024 (57.68) to Mar. 2025 (60.56).


Wanbury Days Sales Outstanding Historical Data

The historical data trend for Wanbury's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbury Days Sales Outstanding Chart

Wanbury Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.20 35.00 48.28 50.04 61.98

Wanbury Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.68 62.25 63.12 76.24 60.56

Competitive Comparison of Wanbury's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbury's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbury's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbury's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Wanbury's Days Sales Outstanding falls into.


;
;

Wanbury Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Wanbury's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

Days Sales Outstanding (A: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (894.438 + 1141.563) / 2 ) / 5995.142*365
=1018.0005 / 5995.142*365
=61.98

Wanbury's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (0 + 1141.563) / 1 ) / 1719.995*365 / 4
=1141.563 / 1719.995*365 / 4
=60.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wanbury  (BOM:524212) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Wanbury Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Wanbury's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbury Business Description

Traded in Other Exchanges
Address
BSEL Techpark, B Wing, 10th Floor, Sector 30-A, Opposite Vashi Railway Station, Vashi, Navi Mumbai, MH, IND, 400703
Wanbury Ltd is engaged in the business of pharmaceutical and related activities including research. Some of the company products are Cpink 50mg table, Rabiplus capsules, Folinine softule, etc. The company has one segment of activity namely Pharmaceuticals. It generates revenue from a contract with customers from the sale of manufactured and traded goods. Geographically, key revenue is generated from outside India.

Wanbury Headlines

No Headlines